Showing 1 posts of 1 posts found.

Merck KGaA hands over CAR-T therapy business to Intrexon in deal worth $175 million

December 20, 2018
Business Services, Medical Communications, Sales and Marketing CAR T, CAR-T, Cancer, Germany, Intrexon, Merck KGaA, darmstadt, oncology

German pharma firm Merck KGaA has agreed to hand over its CAR-T therapy business to US company Intrexon in a …

Latest content